These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34815670)

  • 21. Eradication of large established tumors by drug-loaded bacterial particles via a neutrophil-mediated mechanism.
    Ji G; Li Q; Shen Y; Gan J; Xu L; Wang Y; Luo H; Yang Y; Dong E; Zhang G; Liu B; Yue X; Zhang W; Yang H
    J Control Release; 2021 Jun; 334():52-63. PubMed ID: 33878368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes: cell-created drug delivery systems.
    Familtseva A; Jeremic N; Tyagi SC
    Mol Cell Biochem; 2019 Sep; 459(1-2):1-6. PubMed ID: 31073888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases.
    Chellappan DK; Yee LW; Xuan KY; Kunalan K; Rou LC; Jean LS; Ying LY; Wie LX; Chellian J; Mehta M; Satija S; Singh SK; Gulati M; Dureja H; Da Silva MW; Tambuwala MM; Gupta G; Paudel KR; Wadhwa R; Hansbro PM; Dua K
    Drug Dev Res; 2020 Jun; 81(4):419-436. PubMed ID: 32048757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors.
    Naumenko V; Nikitin A; Garanina A; Melnikov P; Vodopyanov S; Kapitanova K; Potashnikova D; Vishnevskiy D; Alieva I; Ilyasov A; Eletskaya BZ; Abakumov M; Chekhonin V; Majouga A
    Acta Biomater; 2020 Mar; 104():176-187. PubMed ID: 31945505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation.
    Fromen CA; Kelley WJ; Fish MB; Adili R; Noble J; Hoenerhoff MJ; Holinstat M; Eniola-Adefeso O
    ACS Nano; 2017 Nov; 11(11):10797-10807. PubMed ID: 29028303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation.
    Filep JG; Ariel A
    Am J Physiol Cell Physiol; 2020 Sep; 319(3):C510-C532. PubMed ID: 32667864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From structures to functions: insights into exosomes as promising drug delivery vehicles.
    Ren J; He W; Zheng L; Duan H
    Biomater Sci; 2016 May; 4(6):910-21. PubMed ID: 26977477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes as Drug Carriers for Cancer Therapy.
    Pullan JE; Confeld MI; Osborn JK; Kim J; Sarkar K; Mallik S
    Mol Pharm; 2019 May; 16(5):1789-1798. PubMed ID: 30951627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Techniques and Applications of Animal- and Plant-Derived Exosome-Based Drug Delivery System.
    Man F; Wang J; Lu R
    J Biomed Nanotechnol; 2020 Nov; 16(11):1543-1569. PubMed ID: 33461649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes as drug delivery systems: A brief overview and progress update.
    Patil SM; Sawant SS; Kunda NK
    Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes as Actively Targeted Nanocarriers for Cancer Therapy.
    Wang Y; Zhang Y; Cai G; Li Q
    Int J Nanomedicine; 2020; 15():4257-4273. PubMed ID: 32606676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression.
    Shang A; Gu C; Zhou C; Yang Y; Chen C; Zeng B; Wu J; Lu W; Wang W; Sun Z; Li D
    Cell Commun Signal; 2020 Mar; 18(1):52. PubMed ID: 32228650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Insights Into Neutrophil Biology From the Zebrafish Perspective: Lessons From CD18 Deficiency.
    Bader A; Gao J; Rivière T; Schmid B; Walzog B; Maier-Begandt D
    Front Immunol; 2021; 12():677994. PubMed ID: 34557186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation.
    McDonald B; Kubes P
    J Mol Med (Berl); 2011 Nov; 89(11):1079-88. PubMed ID: 21751029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages.
    Park S; Kang S; Chen X; Kim EJ; Kim J; Kim N; Kim J; Jin MM
    Biomaterials; 2013 Jan; 34(2):598-605. PubMed ID: 23099063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosome-based immunotherapy: a promising approach for cancer treatment.
    Xu Z; Zeng S; Gong Z; Yan Y
    Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.